AI x Bio Series: Ginkgo Bioworks CEO Jason Kelly on Engineering Life's Next Operating System

Ginkgo Bioworks CEO Jason Kelly joins Inside the ICE House to explain how Ginkgo is building the infrastructure to make biology programmable at scale — automating the lab work that has long bottlenecked scientific progress and offering experimentation as a cloud-based service to pharma, agriculture, and academic researchers. Kelly also details how a landmark collaboration with OpenAI demonstrated that AI can now autonomously design and iterate on biological experiments, pointing toward a future where the $120 billion spent annually on manual research gets dramatically more productive.